United States Patent and Trademark Office: Latest News, Top Stories & Analysis

Harmony Biosciences Reiterates Confidence in Wakix® (Pitolisant) Patents Following Favorable Decision by US Patent and Trademark Office To Deny Petition for Reexamination

September 4, 2023September 3, 2023 - by MyChesCo

PLYMOUTH MEETING, PA — Harmony Biosciences Holdings, Inc. (Nasdaq: HRMY) recently commented on the favorable decision by the U.S. Patent and Trademark Office (USPTO) to deny a Petition for Reexamination …

Regional

Revolutionary ‘Smart Brain’ Model Revolutionizes Brain Injury Research

June 21, 2023June 20, 2023 - by MyChesCo

VILLANOVA, PA — Villanova University Professor of Mechanical Engineering and Director of the Cellular Biomechanics and Sports Science Laboratory, Qianhong Wu, PhD, has been awarded a second patent for his innovative …

Products and Services

VESTECK’s Remote Surgical Suture System Granted USPTO Patent Approval

June 19, 2023June 18, 2023 - by MyChesCo

WEST CHESTER, PA — VESTECK, Inc. recently announced that the U.S. Patent Application No. 17/841,373 Title: REMOTE SURGICAL SUTURE SYSTEM, has been allowed by the U.S. Patent and Trademark Office …

Regional

Windtree Therapeutics’ Dual Mechanism SERCA2a Activators Receive Patent Approval from USPTO

June 14, 2023June 13, 2023 - by MyChesCo

WARRINGTON, PA — Windtree Therapeutics, Inc. (NasdaqCM: WINT), a biotechnology company, reported that the United States Patent and Trademark Office (USPTO) has issued a Notice of Allowance for its patent …

Regional

InductEV Announces Four Newly Granted U.S. Patents

May 10, 2023May 8, 2023 - by MyChesCo

KING OF PRUSSIA, PA — InductEV (formerly Momentum Dynamics) recently announced four additional U.S. patents issued or allowed by the U.S. Patent Office. These patents are based on the innovation …

Regional

NRx Pharmaceuticals Receives Patent for Neuropsychiatric Treatments

February 26, 2023February 26, 2023 - by MyChesCo

RADNOR, PA — NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) announced that the U.S. Patent and Trademark Office recently issued U.S. Patent No. 11,576,911.

Regional

Windtree Therapeutics Announces Issuance of New Istaroxime Patent from U.S. Patent and Trademark Office

February 26, 2023February 25, 2023 - by MyChesCo

WARRINGTON, PA — Windtree Therapeutics, Inc. (NasdaqCM: WINT) announced that the United States Patent and Trademark Office (USPTO) recently issued U.S. Patent No. 11,583,540, providing expanded patent coverage for istaroxime …

Regional

Windtree Announces Notice of Allowance from the US Patent and Trademark Office for a New Istaroxime Patent

October 31, 2022October 30, 2022 - by MyChesCo

WARRINGTON, PA — Windtree Therapeutics, Inc. (NasdaqCM: WINT) reported that the United States Patent and Trademark Office (USPTO) recently issued a Notice of Allowance of new patent claims for istaroxime …

Products and Services

Zynerba Pharmaceuticals Announces Issuance of New U.S. Patent for Zygel

October 9, 2022October 9, 2022 - by MyChesCo

DEVON, PA — Zynerba Pharmaceuticals, Inc. (Nasdaq: ZYNE) announced that the U.S. Patent and Trademark Office recently issued Patent No. 11,458,110, titled “Treatment of Fragile X Syndrome With Cannabidiol,” which …

Business

A Breakdown of the Trademark Registration Process for Businesses in the Greater Philadelphia Area

February 11, 2021February 10, 2021 - by Josh Gerben

Philly-based businesses of all sizes will benefit from trademark registration. Whether you plan to open a coffee shop in Chestnut Hill or dental practice in West Chester, the time to …